% Expired Patents = 100.0

Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Thomas E Ichim (3 out of 54 patents)

Vladimir Bogin (2 out of 2 patents)

Neil Riordan (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 10869916 - Therapeutic immune modulation by stem cell secreted exosomes (2020-12-22),

2. 9433646 - Methods of inhibiting growth of a neoplastic cell (2016-09-06),

3. 9427450 - Therapeutic immune modulation by stem cell secreted exosomes (2016-08-30),

4. 8895299 - Method for expansion of stem cells (2014-11-25),

Xon Cells, Inc. is a leading biotechnology company focused on developing innovative cell therapies for cancer treatment. Founded in 2010, the company utilizes cutting-edge technology to engineer immune cells to target and destroy cancer cells. With a dedicated team of scientists and researchers, Xon Cells is committed to revolutionizing the way cancer is treated and improving patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#34 in Germantown, MD

#895 in Maryland

#60,597 in US

Germantown, MD, United States of America

Xon Cells, Inc.

Forward Citations = 3

3 inventors:

Thomas E Ichim (3 out of 54 patents)

Vladimir Bogin (2 out of 2 patents)

Neil Riordan (1 out of 2 patents)

Please report any incorrect information to [email protected]